Michael Geffner
Chief Tech/Sci/R&D Officer at IMMUNOVANT, INC.
Net worth: 4 M $ as of 31/05/2024
Michael Geffner active positions
| Companies | Position | Start | End |
|---|---|---|---|
| IMMUNOVANT, INC. | Chief Tech/Sci/R&D Officer | - | - |
Career history of Michael Geffner
Former positions of Michael Geffner
| Companies | Position | Start | End |
|---|---|---|---|
| ACHILLION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | 28/01/2020 |
Training of Michael Geffner
| Albany Medical College | Doctorate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
Statistics
International
| United States | 5 |
Operational
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| IMMUNOVANT, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
- Stock Market
- Insiders
- Michael Geffner
- Experience
